| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |